South African retail giant loses R19.7 billion in five months
Clicks Group has lost over R19 billion in market value in five months, as investors react to slowing growth, mounting competition, and operational challenges that have weighed on the company’s performance.
Clicks is South Africa’s largest retail pharmacy chain, operating over 1,000 stores with roughly 800 in-store pharmacies. It offers prescription medication, cosmetics, baby care, and general health products.
Through its subsidiary, UPD, Clicks also operates as the largest pharmaceutical wholesaler in South Africa, supplying medicines to clinics, hospitals, and pharmacies nationwide.
Despite reporting growth in its interim results for the six months ended 28 February 2026, the market response was sharply negative.
Clicks reported group turnover growth of 7.4% to R24.9 billion, while diluted headline earnings per share increased by 8.1% to 652.8 cents.
The retailer increased its interim dividend by 8.4% to 258 cents per share and generated R1.9 billion in cash from operations.
The company also celebrated the opening of its 1,000th store during the reporting period. However, investors focused on several warning signs contained in the results.
Retail turnover growth was hamstrung by delays in implementing a warehouse management system at the company’s Cape Town distribution centre.
The retailer noted that the disruption affected product availability in Western Cape and Eastern Cape stores, particularly during the festive season.
Clicks’ management estimated that the system delays reduced retail turnover by approximately R175 million.
At the same time, Clicks faced pressure from “aggressive competitor discounting over the festive season”, while margins also came under strain.
The group’s total income margin declined by 30 basis points to 30.7%, while UPD’s trading margin slipped to 2.5%.
The group also warned that consumer spending conditions remain under pressure due to rising fuel prices and inflation, which are squeezing household budgets.
After the interim results were released, Clicks shares plunged more than 8% in a single day to R275.88, despite the higher dividend payout.
Investors were particularly disappointed by management’s guidance for full-year earnings growth of between 4% and 9%, which fell short of analyst expectations.
The selloff has been severe
On 2 January 2026, Clicks shares traded at R332.34, giving the retailer a market capitalisation of roughly R77.7 billion.
By 25 May 2026, the share price had fallen to R248.11, reducing its market value to around R58 billion. This represents a year-to-date decline of approximately R19.7 billion in market capitalisation.
Speaking on BusinessDayTV, analysts said the decline reflects a combination of weaker investor sentiment toward retailers and concerns that Clicks is no longer delivering the exceptional growth that once justified its premium valuation.
Ricus Reeders, wealth manager at PSG Hole In One Ruimsig, said the retailer’s valuation is “reverting to a valuation that’s more representative of where it should be”.
He noted that Clicks had traded at price-to-earnings ratios above 20 for a prolonged period, but argued that the past number of reporting seasons’ earnings no longer justified those levels.
He also warned that Clicks may be losing market share to major competitors, with the dominant one being Dis-Chem.
Shane Watkins, the founder, executive director, and CIO of All Weather Capital, echoed those concerns. “Clicks appears to have lost its way a little bit,” he said.
“The retailer had enjoyed around 15 years of strong growth, but that part of the journey is maybe over,” Watkins said.
“It’s going to do less well in the future because it’s evident that there are some company-specific problems in Clicks.” However, not all analysts are bearish on the retailer.
Aheesh Singh, the CIO at MP9 Asset Management, remained optimistic about the company’s long-term prospects.
Singh argued that despite its historically high valuation, the retailer has consistently delivered earnings growth of about 10% a year while maintaining strong profitability.
“Clicks has been a good quality compounder with high cash conversion and a ROE in the mid-20s, so it’s a solid value bet,” said Singh.
Clicks’ share price performance from May 2025 to May 2026
Loading ...